The stability of Pt-based catalysts is critical to the reliability of proton exchange membrane fuel cells. Here, the authors use stroboscopic operando high energy X-ray scattering to reveal Pt ...
Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi’an 710032, ...
Biologists had long believed that bringing order and organization to the chaos of molecules inside a cell depended on membrane-bound compartments called organelles, such as the mitochondria.
Ubisoft is apparently endeavoring to work with Tencent to bring forth new ventures, one of which is the rumored Splinter Cell Remake. During an address, Guillemot confirmed numerous titles were in ...
According to precedent and due to his status, Yoon will probably be assigned a solitary cell, likely bigger and better appointed than the standard 6.56 square metre (71 square feet) single cells.
Two new cellular agriculture scale-up facilities have opened in the Netherlands, as the country works to strengthen its position as a global leader in the sector and invest in the future of food. The ...
The network is called Lunar Surface Communication System (LSCS), and it is basically a replica of the 4G/LTE cellular technology currently used on a very large scale by the humans of Earth.
(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...
UPDATE 2/9: T-Mobile has since expanded its beta to iPhones running iOS 18.3. And it just revealed in a Super Bowl ad that its cellular Starlink service will launch in July. It'll be free for ...
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...
Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results